An economic evaluation of nivolumab for the treatment of squamous and non-squamous NSCLC in the Swedish setting

• Main Authors: Caitlin Smare (Author), Meena Venkatachalam (Author), Emma Medin (Author), Marcus Hultberg (Author), John R Penrod (Author), Nadine Hertel (Author), Michael Lees (Author), Christoffer Holmberg (Author)
• Format: Book
• Published: University of Oslo, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The cost-effectiveness of nivolumab versus docetaxel in patients with previously treated non-small cell lung cancer (NSCLC) was estimated in a cohort-based, partitioned survival model with three health states (progression-free, progressed disease, and death) and a time horizon of 15 years. The base-...